Mercy Medical Center is a hospital located in Baltimore, Maryland. Mercy has been recognized as the #2 hospital in the State of Maryland for 2014-15 by U.S. News & World Report.

There are 178 beds in Mercy Medical Center.

During the past decade, Mercy Medical Center conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 56 clinical trials were completed, i.e. on average, 64.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 39 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Medical Center" #1 sponsor was "Bristol-Myers Squibb" with 16 trials, followed by "Gilead Sciences" with 14 trials sponsored, "Mercy Medical Center" with 12 trials sponsored, "Hoffmann-La Roche" with 11 trials sponsored and "National Cancer Institute (NCI)" with 11 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Mercy Medical Center" with 3 trials as a collaborator and "NSABP Foundation Inc" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Medical Center" are "Breast Cancer" (18 trials), "Nonalcoholic Steatohepatitis" (9 trials), "Hepatitis C" (5 trials), "Hepatitis C Virus" (5 trials) and "Chronic Hepatitis C" (4 trials). Many other conditions were trialed in "Mercy Medical Center" in a lesser frequency.

Most popular intervention types in "Mercy Medical Center" are "Drug" (103 trials), "Other" (29 trials), "Biological" (17 trials), "Device" (8 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Paclitaxel" (13 trials), "Carboplatin" (10 trials), "Ribavirin" (9 trials) and "Laboratory Biomarker Analysis" (8 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Medical Center" are 122 trials for "All" genders and 26 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Medical Center". undefined are not yet recruiting, 21 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 78 completed trials in Mercy Medical Center, 2 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Medical Center, 4 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 15 trials that are defined as “Not Applicable".

Mercy Medical Center has several departments that took part in Clinical trials: "Mercy Medical Center Medical Oncology & Hematology" - 6 trials, "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" - 4 trials, "The Spine Center" - 3 trials, "Institute for Digestive Health and Liver Disease" - 3 trials, "Institute for Foot and Ankle Reconstruction at Mercy" - 2 trials